WMT

123.78

+0.39%↑

153.82

-0.01%↓

77.1

+0.16%↑

170.04

+0.5%↑

PEP

159.44

-0.72%↓

WMT

123.78

+0.39%↑

153.82

-0.01%↓

77.1

+0.16%↑

170.04

+0.5%↑

PEP

159.44

-0.72%↓

WMT

123.78

+0.39%↑

153.82

-0.01%↓

77.1

+0.16%↑

170.04

+0.5%↑

PEP

159.44

-0.72%↓

WMT

123.78

+0.39%↑

153.82

-0.01%↓

77.1

+0.16%↑

170.04

+0.5%↑

PEP

159.44

-0.72%↓

WMT

123.78

+0.39%↑

153.82

-0.01%↓

77.1

+0.16%↑

170.04

+0.5%↑

PEP

159.44

-0.72%↓

Home・Elenco Azioni・Compass Pathways Plc ADR

Compass Pathways Plc ADR

Chiusa

6.54 -2.97

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

6.46

Massimo

6.79

Metriche Chiave
By Trading Economics
Entrata	-99M -138M
EPS	-0.384
Dipendenti	166
EBITDA	-95M -137M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+217.11% upside

Dividendi
By Dow Jones
Utili prossimi	12 mar 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	226M 797M
Apertura precedente	9.51
Chiusura precedente	6.54

Punteggio Tecnico

By Trading Central

Fiducia

Bearish Evidence

3.645 / 4.0539 Supporto e resistenza

Compass Pathways Plc ADR Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 mar 2026, 19:32 UTC

Acquisizioni, Fusioni, Takeovers

Diana Shipping Increases Offer to Acquire Genco -- Update

6 mar 2026, 17:44 UTC

Acquisizioni, Fusioni, Takeovers

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

6 mar 2026, 22:26 UTC

Principali Notizie su Eventi

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

6 mar 2026, 22:07 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

6 mar 2026, 22:03 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

6 mar 2026, 22:03 UTC

Discorsi di Mercato

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

6 mar 2026, 21:50 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Financial Services Roundup: Market Talk

6 mar 2026, 21:37 UTC

Utili

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

6 mar 2026, 21:25 UTC

Principali Notizie su Eventi

How The Iran War Impacts Ukraine. -- Barrons.com

6 mar 2026, 21:17 UTC

Utili

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

6 mar 2026, 20:50 UTC

Utili

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

6 mar 2026, 20:46 UTC

Utili

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

6 mar 2026, 20:31 UTC

Principali Notizie su Eventi

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

6 mar 2026, 20:18 UTC

Discorsi di Mercato

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

6 mar 2026, 20:12 UTC

Discorsi di Mercato

Principali Notizie su Eventi

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

6 mar 2026, 19:10 UTC

Discorsi di Mercato

Principali Notizie su Eventi

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

6 mar 2026, 18:54 UTC

Discorsi di Mercato

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

6 mar 2026, 18:44 UTC

Discorsi di Mercato

Principali Notizie su Eventi

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

6 mar 2026, 18:08 UTC

Utili

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6 mar 2026, 18:04 UTC

Utili

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6 mar 2026, 18:04 UTC

Utili

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

6 mar 2026, 17:49 UTC

Discorsi di Mercato

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

6 mar 2026, 17:46 UTC

Principali Notizie su Eventi

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

6 mar 2026, 17:40 UTC

Discorsi di Mercato

Utili

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

6 mar 2026, 17:40 UTC

Utili

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

6 mar 2026, 17:32 UTC

Discorsi di Mercato

Principali Notizie su Eventi

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

6 mar 2026, 17:28 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

6 mar 2026, 17:20 UTC

Discorsi di Mercato

Utili

Auto & Transport Roundup: Market Talk

6 mar 2026, 17:20 UTC

Discorsi di Mercato

Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

6 mar 2026, 17:20 UTC

Acquisizioni, Fusioni, Takeovers

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Confronto tra pari

Modifica del prezzo

Compass Pathways Plc ADR Previsione

Obiettivo di Prezzo

By TipRanks

217.11% in crescita

Previsioni per 12 mesi

Media 21.5 USD 217.11%

Alto 70 USD

Basso 8 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Compass Pathways Plc ADR - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

12 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 12 che hanno fornito valutazioni azionarie a Compass Pathways Plc ADR - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

3.645 / 4.0539Supporto e resistenza

Recent bearish events outweigh bullish events.

All events are bullish.

There are no events.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Compass Pathways Plc ADR

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.